Social Media and Cancer Screening Information
Part of paid clinical trials in Salt Lake City, Utah.
- Sponsor
- University of Utah
- Study ID
- NCT06712901
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Median Ranked Cancer Screening Messaging — BEHAVIORALStrong message content that increases screening and sharing intentions. Messages in this intervention were median ranked in the prior study.
- Overall Preferred Cancer Screening Messaging — BEHAVIORALStrong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by all participants in the prior study.
- Black American Preferred Cancer Screening Messaging — BEHAVIORALStrong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by Black participants but not White participants in the prior study.
- White American Preferred Cancer Screening Messaging — BEHAVIORALStrong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by White participants but not Black participants.
- Control — BEHAVIORALThere will be no message content of cancer screening and sharing intentions in this arm.
Study Details
NORC/AmeriSpeak will recruit participants who meet the study criteria and invite them to complete a 15-minute survey. Participants will be randomly assigned to one of five conditions, with approximately 400 people in each condition, and will respond to various questions after viewing the study messaging. Once 2,000 participants complete the survey, the data will be de-identified and provided to the study team for analysis.
Key Dates
- Start date
- Jan 9, 2025
- Status verified
- Mar 2026
- Primary completion
- Jan 21, 2025
- Completion
- Jan 21, 2025
Study Design
- Enrollment
- 2,030 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Placebo Comparator: Control (no exposure)Participants in the Control Arm will not be shown any messages.
- Experimental: Median RankedParticipants in the Median Ranked Arm will be shown four Median Ranked messages.
- Experimental: Overall PreferredParticipants in the Overall Preferred arm will be shown four Overall Preferred messages.
- Experimental: Black American PreferredParticipants in the Black American Preferred arm will be shown four Black American Preferred messages.
- Experimental: White American PreferredParticipants in the White American Preferred arm will be shown four White American Preferred messages.
Primary Outcome Measure
Intentions to Adhere to Colorectal Cancer Screening (CRCS) Recommendations [ Time Frame: 15 minutes ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Andy King | Salt Lake City | Utah | 84112 | - |
Find similar trials in Salt Lake City, UT
By condition
By specialty
By research site
Related Studies
- ColoCare Study - Colorectal Cancer CohortRecruiting · University of Utah · Los Angeles, California
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS AssaysRecruiting · Tempus AI · Fort Smith, Arkansas
- Colonoscopy vs Stool Testing for Older Adults With Colon PolypsRecruiting · Dartmouth-Hitchcock Medical Center · Birmingham, Alabama